Taiwan FDA registration ed738a584ef49c01e1a7447f4aa7c3fc
"Formosa Biomedicine" Cystin C Tube Solution Group (Unsterilized)
TW: "台塑生醫" 胱蛋白C品管液組 (未滅菌)
Taiwan·Risk Class 1·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered Mar 02, 2015 – Mar 02, 2025ExpiredRegistration details
- Analysis ID
- ed738a584ef49c01e1a7447f4aa7c3fc
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- Domestic
Dates and status
- Registration Date
- Mar 02, 2015
- Expiry Date
- Mar 02, 2025
About this record
Access comprehensive regulatory information for "Formosa Biomedicine" Cystin C Tube Solution Group (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number ed738a584ef49c01e1a7447f4aa7c3fc and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices